REGENXBIO Inc. (RGNX) Gross margin 2016–2024
REGENXBIO Inc. (RGNX) gross margin by fiscal year — reported gross profit divided by reported revenue.
59.7%FY2024 · since FY2016: 97.9% → 59.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | 59.7% | +1.0 pp |
| FY2023 | 58.8% | +7.2 pp |
| FY2022 | 51.6% | -37.4 pp |
| FY2021 | 89.0% | +12.1 pp |
| FY2020 | 76.9% | +0.3 pp |
| FY2019 | 76.6% | -19.0 pp |
| FY2018 | 95.6% | +12.0 pp |
| FY2017 | 83.6% | -14.3 pp |
| FY2016 | 97.9% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More RGNX financial trends
RGNX RevenueRGNX Net incomeRGNX Net marginRGNX Gross profitRGNX Operating incomeRGNX Operating marginRGNX Operating cash flowRGNX Free cash flowRGNX Capital expendituresRGNX Return on equityRGNX Stock buybacksRGNX Dividends paidRGNX Total assetsRGNX Total liabilitiesRGNX Shareholders’ equityRGNX overview →